Skip to main content

Arthritis Shoulder

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Medacta
MedactaSwitzerland - Castel San Pietro
1 program
Mirror Medacta Shoulder SystemN/A1 trial
Active Trials
NCT05062252Recruiting100Est. Dec 2027
Nordic Pharma
Nordic PharmaFrance - Paris
1 program
Tornier Ascend Flex stemN/A
Stryker
StrykerCA - San Jose
1 program
Tornier Ascend Flex stemN/A1 trial
Active Trials
NCT05297305Terminated19Est. Nov 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
StrykerTornier Ascend Flex stem
MedactaMirror Medacta Shoulder System

Clinical Trials (2)

Total enrollment: 119 patients across 2 trials

NCT05297305StrykerTornier Ascend Flex stem

Onlay Versus Inlay Humeral Component in Reverse Total Shoulder Arthroplasty

Start: Oct 2023Est. completion: Nov 202519 patients
N/ATerminated
NCT05062252MedactaMirror Medacta Shoulder System

Mirror Medacta Shoulder System Pivotal Trial

Start: Jan 2022Est. completion: Dec 2027100 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 119 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.